NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

24 October 2023

EMIS GROUP PLC

("EMIS" OR THE "cOMPANY")

ADMISSION OF SHARES

On 17 June 2022, the Boards of Bordeaux UK Holdings II Limited ("Bidco") (an affiliate of Optum Health Solutions (UK) Limited) and EMIS announced that they had reached agreement on the terms of a recommended all cash offer pursuant to which Bidco will acquire the entire issued and to be issued ordinary share capital of EMIS (the "Acquisition").  The Acquisition is being implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

In connection with the Acquisition, and to satisfy awards held by employees of EMIS and its subsidiaries under the Company's established share option plans, which awards will vest and become exercisable upon Court sanction of the Scheme, EMIS announces that it has applied for 846,034 ordinary shares of £0.01 each in the capital of EMIS to be admitted to trading on AIM ("Admission").

Admission is expected to take place at 8.00 a.m. on 25 October 2023.

Enquiries:

Travers Smith LLP are retained as legal adviser to EMIS and Slaughter and May are retained as legal adviser to Bidco and UnitedHealth Group.